
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 22, 2021, titled "Glenmark and Bausch Health join together to commercialize RYALTRIS nasal spray in Canada".
Filed with NSE · · 3 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 22, 2021, titled "Glenmark and Bausch Health join together to commercialize RYALTRIS nasal spray in Canada".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals